Global C – Reactive Protein Testing Market, By Assay Type (Enzyme Linked Immunosorbent Assay, Chemiluminiesence Immunoassay, Immunoturbidimetric Assay, Others), Type of Test (Molecular, Serology), Full Test Time (5 Minutes, 5-15 Minutes, 15-60 Minutes, 1 Hours- 5 Hours, 5 Hours-12 Hours, 12 Hours-24 Hours, More Than 1 Days), Use (Disposable, Reusable), Mobility (Portable, Stationary), Technology (RT-PCR, Immunoglobulin G, Immunoglobulin M, ELISA Test, Micro-neutralization Assays), Disease Area (Cancer, Lupus), Application (Cardiovascular Disease, Inflammatory Bowel Disease, Diabetes, Rheumatoid Arthritis and Others), End Use (Hospitals, Clinics, Public Health Labs, Private or Commercial Labs, Physician Labs, Research Institutes, Assisted Living Healthcare Facilities, Home, Others) – Industry Trends and Forecast to 2029.
C – Reactive Protein Testing Market Analysis and Size
C – reactive protein testing can be used to detect or monitor significant inflammation in people who are suspected of having an acute condition like sepsis, a fungal infection, or Pelvic inflammatory disease (PID). The test can help people with chronic inflammatory conditions detect flare-ups. Inflammatory bowel disease, some types of arthritis, and autoimmune diseases such as lupus or vasculitis are examples. The determination of CRP levels is helpful in monitoring therapy. It is performed following surgery to check for infection. CRP levels typically rise within 2 to 6 hours of surgery and then fall by the third day.
Data Bridge Market Research analyses that the C – reactive protein testing market which was USD 1,750.27 million in 2021, is expected to reach USD 1,995.10 million by 2029, at a CAGR of 1.65% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
C – Reactive Protein Testing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Assay Type (Enzyme Linked Immunosorbent Assay, Chemiluminiesence Immunoassay, Immunoturbidimetric Assay, Others), Type of Test (Molecular, Serology), Full Test Time (5 Minutes, 5-15 Minutes, 15-60 Minutes, 1 Hours- 5 Hours, 5 Hours-12 Hours, 12 Hours-24 Hours, More Than 1 Days), Use (Disposable, Reusable), Mobility (Portable, Stationary), Technology (RT-PCR, Immunoglobulin G, Immunoglobulin M, ELISA Test, Micro-neutralization Assays), Disease Area (Cancer, Lupus), Application (Cardiovascular Disease, Inflammatory Bowel Disease, Diabetes, Rheumatoid Arthritis and Others), End Use (Hospitals, Clinics, Public Health Labs, Private or Commercial Labs, Physician Labs, Research Institutes, Assisted Living Healthcare Facilities, Home, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher (U.S.), Quest Diagnostics Incorporated (U.S.), Siemens Healthineers AG (Germany), Abbott (U.S), Merck KGaAA (Germany), Zoetis (U.S.), Ortho Clinical Diagnostics (U.S.), Getein Biotech, Inc. (China), HORIBA, Ltd (Japan), Randox Laboratories Ltd. (U.K), BODITECH MED, INC. (South Korea), Aidian (Finland)
|
|
Market Opportunities
|
|
Market Definition
The C-reactive protein (CRP) test is used to determine the amount of c-reactive protein (CRP) in the blood. The c-reactive protein (CRP) test is used to check for infections or other medical disorders, and it rises when there is inflammation. The c-reactive protein test is used to assess the risk of developing cardiovascular disorders including coronary artery disease, which can lead to a major heart attack.
Global C – Reactive Protein Testing Market Dynamics
Drivers
• Increasing incidence of inflammatory disorders
Inflammatory disorders such as inflammatory bowel disease, endometriosis, cancer, rheumatoid arthritis, cardiovascular disease, and lupus are all diagnosed with C-reactive protein tests. When high CRP is combined with other risk factors such hypertension, high blood pressure, diabetes, and high cholesterol, it can suggest significant heart disease. Early identification of these disorders can greatly lower the risk of heart attacks and strokes. CRP is used in the discovery of novel medicines for inflammatory illnesses in vitro and in vivo. These all are the certain factors which helps the market to grow.
• Growing cases of endometriosis in women
Endometriosis is a condition in which the uterine tissue grows outside of the uterus. The disease most commonly affected a woman's ovaries, fallopian tubes, and pelvic tissue. The disease has the potential to expand beyond the pelvic area. Endometriosis patients have a higher sensitivity to C-reactive protein than non-endometriosis patients. As a result, the test is widely used to detect the disease in patients and boost the growth of the market.
- Exponential increase in research on various applications of the C-reactive protein
The increased use of techniques such as point-of-care (POC) based testing for reliable findings, as well as approvals of C-reactive protein testing for the diagnosis of bacterial and non-bacterial infections, are projected to boost market growth. Furthermore, the incidence of cardiovascular disorders is rising, as is the number of tests required.
Opportunities
- Technological advancements will boost the growth rate
Plasmonic nanoparticles (PNPs) are among the tools that can be used for biosensing applications due to their versatile optical properties. A study published in July 2021 by researchers from BabeTM-Bolyai University in Romania provided an overview of plasmonic nanoparticles-based assays for C-reactive protein (CRP) detection. Furthermore, the study demonstrated the use of newly designed point-of-care assays for rapid CRP testing. Such advancements are expected to accelerate market growth in the near future.
Restraints/Challenges
- High cost of C–reactive protein testing
High cost of c–reactive protein testing and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. CRP Test Cost max is in RequestATest (C-Reactive Protein (CRP) Quantitative Blood Test) with price $59.00. This laboratory test is available in 13 online lab test stores.
This C – reactive protein testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the C – reactive protein testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the C – Reactive Protein Testing Market
The continuing COVID-19 epidemic is likely to boost the market's performance. CRP has been evaluated as a prognostic predictor in COVID-19 patients in a number of studies. For example, in November 2020, researchers from the United States published a paper. The study found that daily CRP readings are useful in COVID-19 patients who are hospitalised. CRP levels can potentially be used as early warning indicators. The need for CRP testing in the region is expected to rise as a result of these investigations.
Recent developments
- In March 2021, the company also announced the construction of a new R&D Center in Chuncheon, South Korea with an investment of USD 6 million. This center is expected to be operational by March 2022.
Global C – Reactive Protein Testing Market Scope
The C – reactive protein testing market is segmented on the basis of assay type, disease area, application, type of test, full test time, use, mobility and technology and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Assay Type
- Enzyme Linked Immunosorbent assay
- Chemiluminiesence Immunoassay
- Immunoturbidimetric Assay
- Others
Disease Area
- Cancer
- Lupus
Application
- Cardiovascular disease
- Inflammatory Bowel Disease
- Diabetes
- Rheumatoid Arthritis
- Others
Type of Test
- Molecular
- Serology
Full Test Time
- 5 Minutes
- 5-15 Minutes
- 15-60 Minutes
- 1 Hours- 5 Hours
- 5 Hours-12 Hours
- 12 Hours-24 Hours
- More Than 1 Days
Use
- Disposable
- Reusable
Mobility
- Portable
- Stationary
Technology
- RT-PCR
- Immunoglobulin G
- Immunoglobulin M
- ELISA Test
- Clinical
- Non-clinical
- Micro-neutralization Assays
End Use
- Clinics
- Entity
- Physician Offices
- Small Clinics
- Others
- Settings
- Urban Setting
- Rural Setting
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Public Health Labs
- Private or Commercial Labs
- Physician Labs
- Research Institutes
- Others
C – Reactive Protein Testing Market Regional Analysis/Insights
The C – reactive protein testing market is analysed and market size insights and trends are provided by country, assay type, disease area, application, type of test, full test time, use, mobility and technology and end use as referenced above.
The countries covered in the C – reactive protein testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the C – reactive protein testing market due to the factor of favourable reimbursement policies. For instance, Blue Cross coverage for general inflammation testing includes coverage for CRP measurement in the diagnosis of inflammatory disorders.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to growing government initiative toward R&D projects and improving the healthcare sector. Furthermore, technological advancements will drive market growth in the coming years. Some researchers developed a real-time flexible sensor that is integrated into a medical catheter for direct CRP sensing.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The C – reactive protein testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for C – reactive protein testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the C – reactive protein testing market. The data is available for historic period 2010-2020.
Competitive Landscape and C – Reactive Protein Testing Market Share Analysis
The C – reactive protein testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to C – reactive protein testing market.
Some of the major players operating in the C – reactive protein testing market are:
- Thermo Fisher Scientific, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Danaher (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Siemens Healthineers AG (Germany)
- Abbott (U.S)
- Merck KGaAA (Germany)
- Zoetis (U.S.)
- Ortho Clinical Diagnostics (U.S.)
- Getein Biotech, Inc. (China)
- HORIBA, Ltd (Japan)
- Randox Laboratories Ltd. (U.K)
- BODITECH MED, INC. (South Korea)
- Aidian (Finland)
SKU-